Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed May 23, 2023 · 10-Q · 53 days after period end · 0001477932-23-003889
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$389.74K | -$2.80M | -$334.44K | -$292.96K |
| EPS Diluted | — | — | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 23, 2023 · 53 d after period end
